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Abstract Cyclosporin (CsA) inhibits mitochondrial death sig-
naling and opposes tumor necrosis factor (TNF)-induced
apoptosis in vitro. However, CsA is also a potent inhibitor of
calcineurin, a phosphatase that may participate in cell death.
Therefore, we tested the hypothesis that calcineurin regulates
TNF cytotoxicity in rat hepatoma cells (FTO2B). TNF-treated
FTO2B cells appeared apoptotic by DNA fragmentation, nuclear
condensation, annexin V binding, and caspase activation. We
studied two calcineurin inhibitors, CsA and FK506, and found
that each potently inhibited TNF cytotoxicity. Western blot
demonstrated calcineurin in FTO2B homogenates. In a model of
mitochondrial permeability transition (MPT), we found that CsA
prevented MPT and cytochrome c release, while FK506 inhibited
neither. In summary, we present evidence that calcineurin
participates in an apoptotic death pathway activated by TNF.
CsA may oppose programmed cell death by inhibiting calcineurin
activity and/or inhibiting mitochondrial signaling. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Tumor necrosis factor (TNF) binds to receptors on the cell
surface that can activate death pathways. Cytoprotective re-
sponses limit the susceptibility of most normal and neoplastic
cells to TNF in a complex, transcription-dependent process,
mediated in part by transcription factors AP-1 and NFUB
[1,2]. Inhibitors of transcription or protein synthesis (e.g. ac-
tinomycin D (Act D) or cycloheximide) sensitize resistant cells
to TNF and allow unopposed activation of proteins in the
death pathway.
Aggregation of TNF receptors on the cell surface activates
caspases, a family of constitutive proteins with a central role
in death pathways [3]. Caspase activation occurs when pro-
caspases interact with receptor death domains. Receptor-asso-
ciated caspases (e.g. caspase-8) then activate downstream pro-
caspases by proteolytic cleavage. These downstream caspases
cleave both structural and regulatory proteins, leading to ap-
optotic disassembly of the cell. Caspase activation does not
require transcription and synthesis of new protein, but may be
regulated by compartmentalization and by inhibitory proteins.
Inhibition of caspases with synthetic oligopeptides (Z-Val-
Ala-Asp-CH2F (zVAD.fmk)) and naturally occurring viral
products (CrmA, baculovirus) opposes apoptosis due to oxi-
dative stress, irradiation, TNF, Fas ligand, and staurosporine.
Recently, a role for mitochondria in the regulation of cell
death has become apparent. In the highly TNF-sensitive L929
cell line, release of reactive oxygen species from mitochondria
occurs early after TNF exposure, and antioxidant strategies
promote cell survival [4]. In apoptosis in a variety of other
systems, cytochrome c, apoptosis-activating factor, and pro-
caspase-3 are released from mitochondria and interact with
caspases and proteins of the bcl-2 family to mediate cell death
[5^7]. Release of these signaling proteins from mitochondria
occurs after permeability pores in the inner mitochondrial
membrane open and the organelle swells. Cyclosporin A
(CsA) prevents the mitochondrial permeability transition
(MPT) in vitro by binding to a cyclophilin-like isomerase in
the mitochondrial membrane [8,9]. CsA may oppose TNF
cytotoxicity in vivo by inhibiting MPT and release of signaling
molecules [10].
In addition to its e¡ects on mitochondria, CsA potently
inhibits calcineurin (CN), a widely distributed serine-threonine
phosphatase that plays a key role in immune suppression
[11,12]. CN has been implicated in calcium-dependent death
pathways in thymocytes [13] and neural tissues [14], and may
in£uence mitochondrial death signaling via direct interaction
with bcl-2 [15^17] and dephosphorylation of bad [18].
Although caspase activation and mitochondrial signaling ap-
pear to have prominent roles in death pathways activated by
TNF, the role of CN in TNF cytotoxicity has not been de-
termined. In this report, we present evidence that CN partic-
ipates in TNF-mediated apoptosis in the rat hepatoma
(FTO2B) cells.
2. Materials and methods
2.1. Cytokines, reagents and cells
Recombinant rat TNF-K (speci¢c activity 1.33U108 U/mg per L929
bioassay) was purchased from Genzyme. FK506 was generously pro-
vided by Fujisawa. zVAD.fmk was purchased from Kamiya Biomed-
ical Co.
FTO2B cells were cultured in DMEM/F-12 supplemented with 10%
fetal calf serum, 7.5% (w/v) sodium bicarbonate, 2 mM glutamine,
penicillin (100 U/ml) and streptomycin (0.1 mg/ml) at 37‡C. Plates
were coated with gelatin in Williams E media supplemented with
HEPES, glutamine, insulin, penicillin and streptomycin.
2.2. Cytotoxicity assay
Cells were removed from the plates using trypsin, counted on a
hemocytometer, and plated at a density of 2.5U105 per well on gel-
atin-coated 12-well plates. Cells were allowed to adhere overnight, and
then incubated in fresh media containing Act D (1 Wg/ml) or TNF
(500 U/ml)+Act D. For all experiments, the following inhibitor con-
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 2 0 8 3 - 4
*Corresponding author. Fax: (1)-504-568 4295.
E-mail: skantr@lsumc.edu
FEBS 24191 12-10-00
FEBS 24191 FEBS Letters 483 (2000) 119^124
centrations were used: 1 WM CsA, 100 nM FK506 or 20 WM
zVAD.fmk. Maximal (100%) killing was determined by adding Triton
X-100 (¢nal concentration 0.5%) to cells incubated with Act D. Lac-
tate dehydrogenase (LDH) activity in the supernatant was determined
at 0, 12 and 18 h using LDH reagent and measuring the rate of
change in absorbance at 340 nm for 6 min in a microplate reader.
All experiments were performed in triplicate.
2.3. Western blots
For CN immunoassays, cells were grown in T75 £asks to 2U107
cells per £ask, and the cells were trypsinized, centrifuged, washed and
disrupted with three passes in an Elvejiem^Potter glass homogenizer
in 0.5 ml of cold lysis bu¡er with anti-proteases (150 mM NaCl, 50
mM Tris, pH 7.6, 1% sodium dodecyl sulfate (SDS), 3% Nonidet
P-40, 5 mM ethylene diamine tetra-acetic acid (EDTA), 1 mM MgCl2,
2 mM 1,3-dichloroisocoumarin, 2 mM 1,10-phenanthroline, and 0.4
mM E-64). After centrifugation at 10 000 rpm for 10 min, the super-
natant was stored at 320‡C. Cytosol extracts in lysis bu¡er were
mixed with an equal volume of Laemmli sample bu¡er with 2% mer-
captoethanol. Electrophoresis was performed on 12% polyacrylamide
gels with 0.1% SDS using a mini-gel system. Lanes were loaded with
10^25 Wg of sample protein and electrophoresed for 1.5 h at 100 V.
Proteins were then electrotransferred to nitrocellulose paper, and
blocked overnight at 4‡C in Tris-bu¡ered saline (TBS) with 0.02%
sodium azide and 5% non-fat dry milk. Western blots were then
prepared using murine antibody to the native form of CN subunit
A and subunit B (Sigma). Membranes were incubated for 1 h at 25‡C
with primary antibody (1:3000) in TBS/5% milk, washed three times
in TBS/0.05% Tween (TTBS), and incubated with biotinylated goat
anti-mouse antibody for 1 h at 25‡C. After three additional washes
with TTBS, the membranes were incubated with avidin^horseradish
peroxidase (HRP) (1:3000) and signal was detected by electrochemi-
luminescence (Pierce). All materials used in the preparation of the
Western blots were obtained from Bio-Rad.
For cytochrome c Western blots, samples of supernatant from mi-
tochondrial suspensions were collected as described below. After di-
lution with Laemmli sample bu¡er (1:1), 25 Wl of each sample was
loaded on a 12% polyacrylamide gel and electrophoresed for 1.5 h at
100 V. After blocking overnight, membranes were incubated for 1 h at
25‡C at mouse anti-cytochrome c (Pharmingen) (1:1000). After rins-
ing, the membrane was incubated for 1 h with anti-mouse IgG^biotin
conjugate (Sigma) (1:20 000), rinsed and incubated for 1 h with avi-
din^HRP conjugate (1:3000). Signal was detected by chemilumines-
cence (ECL from Amersham).
2.4. DNA electrophoresis
For each experiment, DNA was isolated from 2U106 cells using an
apoptotic DNA ladder kit (Boehringer Mannheim). Cells were added
to DNA binding bu¡er (6 M guanidine^HCl, 10 mM urea, 10 mM
Tris^HCl (pH 4.4), 20% Triton X-100) and applied to a glass £eece
¢lter tube. After washing with 80% ethanol in 20 mM NaCl and 2 mM
Tris^HCl (pH 8.5), DNA was eluted in 10 mM Tris^HCl (pH 8.5) and
assayed immediately. Samples were added to 30% glycerol and elec-
trophoresed on a 1% agarose gel with ethidium bromide for 1^1.5 h at
75 V. DNA was illuminated with an ultraviolet light source and pho-
tographed.
2.5. Nuclear morphology
Cells were ¢xed in 4% paraformaldehyde at 25‡C for 30 min, then
washed twice with phosphate-bu¡ered saline (PBS). The cell pellet
(approximately 106 cells) was then resuspended in 200 Wg/ml lysophos-
phatidyl choline with 5 U of RNase and 10 Wg propidium iodide at
37‡C for 30 min. Cells were then transferred to slides and examined
immediately with a £uorescent microscope (Nikon TE300) using a
rhodamine ¢lter.
2.6. Flow cytometry
Cell binding of annexin and permeability to propidium iodide were
assessed by £ow cytometry in order to assess the extent of apoptosis
[19]. In normal cells, phosphatidylserine (PS) is located on the cyto-
plasmic surface of the cell membrane, but in cells undergoing apopto-
sis, this phospholipid orientation is reversed. In impermeable cells
early in apoptosis, annexin V binds to the PS on the surface of the
cell. In cells undergoing necrosis or late in apoptosis, the cell mem-
brane is permeable to the nucleic acid stain propidium iodide, and
annexin V binds to PS on the cytoplasmic surface. Fresh cells treated
with TNF were removed from the £ask, washed with cold PBS and
suspended at 106 cells/ml in bu¡er (10 mM HEPES, 140 mM NaCl,
2.5 mM CaCl2, pH 7.4). Cells were then incubated with annexin V
conjugated to a £uorophore (Molecular Probes) and propidium iodide
(1 Wg/ml) at 25‡C for 15 min, and then assayed by £ow cytometry
(FACSCalibur; Becton Dickinson).
2.7. Caspase activity
Determinations of caspase activity were carried out in 96-well plates
using cell lysate from 2U106 cells for each measurement. Caspase
activation was measured in cells treated with TNF+Act D or Act D
alone for 6 h. Lysis bu¡er, reaction bu¡er and colorimetric substrates
for caspases were obtained from RpD Systems. For caspase-3 deter-
minations, DEVD-pNA (caspase substrate conjugated to p-nitroani-
line) was added to the reaction mixture, and after a 2 h incubation at
37‡C, absorbance was measured at 405 nm. Caspase-8 activity was
measured by substituting the colorimetric substrate IETD-pNA for
DEVD. For determination of caspase inhibition, cells were incubated
with zVAD.fmk and TNF+Act D for 6 h prior to preparation of the
cell lysate.
2.8. MPT and cytochrome c release
Rat liver mitochondria were isolated from Sprague^Dawley rats
(300^400 g) using a density gradient centrifugation as previously de-
scribed [20]. The permeability transition was detected by measuring
absorbance at 540 nm (A540) of mitochondria (0.3 mg/ml) suspended
in MPT bu¡er (100 mM KCl, 75 mM mannitol, 25 mM sucrose, 5 mM
Tris^phosphate (pH 7.4), 10 mM Tris^HCl (pH 7.4), 0.05 mM
EDTA and 5 mM succinate) [21]. The permeability transition was
activated by the addition of 300 WM CaCl2 to suspensions of control
mitochondria or to suspensions containing 1^50 WM CsA or 100 nM
to 50 WM FK506. To determine release of cytochrome c, freshly iso-
lated rat liver mitochondria (respiratory control ratio of 4^5) were
suspended in MPT bu¡er at 5 mg/ml. 5 min after addition of CaCl2
and/or inhibitors (1 WM CsA; 100 nM FK506 þ 2 Wg/ml FKBP), the
mitochondrial suspensions were centrifuged (16 000Ug for 1 min) and
supernatants stored at 380‡C.
2.9. Statistical analysis
Statistical analyses were performed using the paired or unpaired
Student’s t test for comparison of means or analysis of variance (AN-
OVA) for repeated measures.
3. Results
3.1. Characterization of cell death
FTO2B cells were incubated with TNF+Act D for 12 h,
permeabilized and stained with propidium iodide in the pres-
ence of RNase. Examination of treated cells by £uorescent
microscopy demonstrated discrete clumping of nuclear chro-
matin in the majority (Fig. 1A). Staining of control cells
(treated with Act D alone) demonstrated di¡use, homogene-
ous £uorescence of the nuclei, with rare clumping of chroma-
C
Fig. 1. Characterization of cell death. A: Nuclear morphology. Propidium iodide stain demonstrates altered nuclear morphology of FTO2B
cells after 12 h exposure to Act D (1 Wg/ml) (top) or TNF (500 U/ml)+Act D (1 Wg/ml) (bottom). B: DNA fragmentation. Electrophoresis of
DNA extracted from FTO2B cells after 24 h exposure to TNF+Act D demonstrates DNA fragmentation compared with control (treated with
Act D alone). C: Annexin binding. Flow cytometry of cells incubated with annexin V and propidium iodide after incubation with Act D (top)
or TNF+Act D for 12 h (bottom). Control cells demonstrate impermeability to propidium iodide (y axis, FL3) and no signi¢cant annexin bind-
ing (x axis, FL1), while treated cells are impermeable to propidium iodide and bind annexin.
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tin. The morphological changes after exposure to TNF were
consistent with chromatin condensation and formation of ap-
optotic bodies.
DNA isolated from cells after incubation with TNF+Act D
for 24 h was characterized by electrophoresis. The gel pattern
observed was consistent with apoptosis, in which DNA cleav-
age by endonucleases results in fragments in multiples of 180^
200 bp (Fig. 1B). Control cells incubated with Act D demon-
strated genomic DNA of high molecular weight, with no evi-
dence of DNA fragmentation.
Cells treated with TNF+Act D for 12 h were incubated
with annexin V and propidium iodide. We found that
V70% of FTO2B cells treated with TNF+Act D bound an-
nexin V but not propidium iodide, consistent with apoptosis.
The remaining cells (V30%) demonstrated binding of both
annexin V and propidium iodide, consistent with either ne-
crosis or late apoptosis (Fig. 1C).
Assay of caspase activation demonstrated increases in cas-
pase-3 and caspase-8 after treatment with TNF+Act D within
6 h (Fig. 2). This activation occurred before any signi¢cant
cell death was detected by LDH release. Incubation of cells
with the non-selective caspase inhibitor zVAD.fmk inhibited
caspase-3 and caspase-8 activity.
3.2. E¡ect of CN inhibition on TNF cytotoxicity
Incubation of FTO2B cells with 1 WM CsA or 100 nM
FK506 during treatment with TNF+Act D potently inhibited
cytotoxicity (Fig. 3A). Treatment with Act D, CsA or FK506
alone did not cause release of LDH from cells over the 18 h
incubation (data not shown). The intact CN protein dimer
(V80 kDa) was present in FTO2B cells by Western blot for
CN subunit A (Fig. 3B) and subunit B (Fig. 3C).
3.3. E¡ect of CN inhibitors on the MPT
Well-coupled, isolated rat liver mitochondria were induced
to undergo the permeability transition by adding calcium to a
mitochondrial suspension, and then following the change in
absorbance (A540) for 20 min. CsA but not FK506 ( þ FKBP)
inhibited the calcium-dependent permeability transition in vi-
tro (Fig. 4A). Western blot demonstrated potent inhibition of
cytochrome c release from isolated rat liver mitochondria by
CsA, but no e¡ect of FK506 on cytochrome c release (Fig.
4B).
4. Discussion
In the FTO2B cell line, TNF caused death with features
typical of apoptosis : nuclear condensation, DNA fragmenta-
Fig. 2. Caspase activation in TNF-treated FTO2B cells. Caspase-3
and caspase-8 activity increase in FTO2B cells treated with
TNF+Act D for 6 h, while both are inhibited by zVAD.fmk
(*P6 0.05).
Fig. 3. E¡ect of CN inhibition on TNF cytotoxicity. A: Cytotoxic-
ity determined by LDH release for FTO2B cells treated with
TNF+Act D is inhibited by cyclosporin A or FK506 (*P6 0.05 by
ANOVA). B: Western blot for CN subunit A demonstrates CN
protein in cytosol of untreated FTO2B cells (positive control: rat
brain). C: Western blot for CN subunit B con¢rms CN protein in
FTO2B cells, migrating at a molecular weight consistent with the in-
tact dimer.
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tion, annexin binding, and activation of the caspase pathway.
TNF cytotoxicity in several cell types and in vitro systems
proceeds to death via a pathway consistent with apoptosis
[22], however, TNF cytotoxicity may also produce death
with features of necrosis (e.g. L929 cells, ¢broblasts [23]). In
both apoptosis and necrosis, death signaling via the MPT may
be important. The term ‘necroptosis’ has been proposed to
emphasize the potential regulatory overlap in these processes
[24].
Potent inhibition of TNF cytotoxicity in hepatoma cells by
two CN inhibitors, CsA and FK506, suggests that CN partic-
ipates in a death pathway activated by TNF. The protection
observed with FK506 does not appear to be due to inhibition
of mitochondrial signaling, as FK506 was without e¡ect on
the MPT and cytochrome c release in rat liver mitochondria.
In addition, no e¡ect of FK506 on the MPT was observed in
mitochondria isolated from rat kidney [25]. However, we did
not characterize mitochondrial signaling in intact hepatoma
cells, and our ¢ndings do not exclude a role for mitochondria
in this pathway.
CN is a calcium-dependent phosphatase present in the cy-
tosol as a heterodimer, with a 58^64 kDa catalytic and cal-
modulin binding portion (subunit A), and a 19 kDa calcium
binding regulatory portion (subunit B) [26]. An iron^zinc met-
al center in the active site of subunit A is required for the
phosphatase activity, and oxidation of the iron reversibly in-
hibits activity. The original substrate speci¢city described for
CN included dephosphorylation of the cytosolic transcription
regulator, nuclear factor activated T cells (NFAT). Dephos-
phorylation of NFAT and its translocation to the nucleus is
followed by induction of several cytokines, including interleu-
kin-2, interleukin-4 and TNF. Because cyclosporin A and
FK506 potently inhibit CN activity and NFAT-mediated im-
mune events, they have become critical immunosuppressant
therapies in organ transplantation.
The clinical use of cyclosporin A and FK506 for immuno-
suppression in humans is associated with an increased risk for
malignancies, including squamous cell cancer, Kaposi’s sarco-
ma, cervical carcinoma, and lymphoproliferative disorder.
Clonal expansion of B cells in lymphoproliferative disorder
has been attributed to viral infection in the setting of de-
pressed T cell function, while decreased immune surveillance
and increased exposure to TGF-L may contribute to solid
tumor proliferation [27]. Altered regulation of cell death
may also participate in neoplasia, and a role for CN in the
regulation of cell death has been proposed for neurons and
immune cells.
In cerebellar granule cells treated in culture with glutamate,
apoptotic death was inhibited by either CsA or FK506 [14]. In
cultured retinal neurons, brief exposure to glutamate resulted
in cell death that was prevented by inhibitors of CN activity
[28]. Thymocytes treated with thapsigargin to raise intracellu-
lar calcium levels are induced to undergo DNA fragmenta-
tion, and this fragmentation is prevented by treatment with
CsA or FK506 [13]. Apoptosis in a B cell line from human
Burkitt’s lymphoma induced by anti-IgM antibody was also
prevented by treatment with FK506 [29]. CN inhibitors also
prevent apoptosis in a T cell hybridoma line, suggesting that
CN is a critical mediator of T cell receptor/CD3 death signal-
ing [30,31].
Important interactions may occur between CN and mem-
bers of the bcl-2 family of pro- and anti-apoptotic proteins. In
baby hamster kidney (BHK) cells transfected with DNA en-
coding CN subunits A and B, CN expression increased sensi-
tivity to calcium-induced death [15]. Co-expression of anti-ap-
optotic protein bcl-2 inhibited CN-dependent apoptosis in this
model, and direct interaction of bcl-2 with the cytosolic CN
was observed. The pro-apoptotic protein bax interfered with
co-localization of CN and bcl-2 [17]. Bad, another pro-apo-
ptotic member of the bcl-2 family, appears to be a substrate
for the phosphatase activity of CN [18]. Interactions between
CN and the bcl-2 family described in the transfected BHK
cells suggest a mechanism for regulation of mitochondrial
death signaling by CN activity.
In summary, we report that TNF-mediated death in rat
hepatoma cells is regulated by CN. In this model of apoptosis,
treatment with CsA can oppose cell death via CN inhibition,
and this e¡ect should be considered in studies of the e¡ect of
Fig. 4. E¡ect of CN inhibitors on MPT and cytochrome c release.
A: Change in absorbance of mitochondrial suspension (0.3 mg/ml)
over time at 540 nm after addition of calcium chloride is inhibited
by 10 WM CsA but not 10 WM FK506. Addition of FKBP (1 Wg/
ml) did not a¡ect MPT (data not shown). B: Release of cytochrome
c from isolated rat liver mitochondria is inhibited by 1 WM CsA,
but not 100 nM FK506.
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CsA on the MPT. Finally, in organ transplant recipients
treated with CsA or FK506, inhibition of CN-dependent
death pathways may prevent apoptosis and result in progres-
sion of lymphatic and epithelial tumors.
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